As 2026 approaches, the clinical research and development landscape is evolving beyond traditional scientific innovation with ...
Natera Inc., a cell-free DNA and precision medicine company, has acquired Foresight Diagnostics, a leader in ultrasensitive ...
Jubilant Therapeutics Inc., a clinical-stage biopharmaceutical company, has appointed Daniel J. O'Connor as President & Chief ...
The FDA has approved BMS’ Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed CAR T cell therapy, for adults with ...
Franco Negron of Simtra Biopharma Solutions shares insight on the sterile liquids manufacturing space.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback